5344:TSEMARUWA CO., LTD. Analysis
Data as of 2026-03-15 - not real-time
NT$14.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at TWD 14, which sits just above the 20‑day SMA (≈14.20) and the 200‑day SMA (≈14.19) but slightly below the 50‑day SMA (≈14.59), suggesting a neutral price stance. RSI sits at 45.7, indicating neither overbought nor oversold conditions, while the MACD line has just crossed above its signal line, producing a tiny positive histogram and a bullish signal. Volume is on an upward trend, yet the 30‑day volatility is high at roughly 33%, and the beta of around 0.5‑0.7 points to modest market sensitivity. Support is anchored near 13 and resistance near 15.1, framing a narrow trading range as market sentiment leans toward Greed (fear‑greed index 72.9).
Fundamentally, the company posted 12% revenue growth but suffers from thin gross margins (≈5.7%) and negative operating and profit margins, with a trailing EPS of –0.39 and an EBITDA of only TWD 16.4 M. The balance sheet shows ample cash (≈TWD 175 M) versus relatively modest debt (≈TWD 36.6 M), yet the debt‑to‑equity ratio is high at over 7, and cash‑flow generation is negative. With a price‑to‑book of 2.25 and a price‑to‑sales of 3.27, the valuation is not cheap relative to its earnings weakness, and the company does not pay a dividend.
Fundamentally, the company posted 12% revenue growth but suffers from thin gross margins (≈5.7%) and negative operating and profit margins, with a trailing EPS of –0.39 and an EBITDA of only TWD 16.4 M. The balance sheet shows ample cash (≈TWD 175 M) versus relatively modest debt (≈TWD 36.6 M), yet the debt‑to‑equity ratio is high at over 7, and cash‑flow generation is negative. With a price‑to‑book of 2.25 and a price‑to‑sales of 3.27, the valuation is not cheap relative to its earnings weakness, and the company does not pay a dividend.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bullish MACD crossover
- Price near immediate support at 13
- Negative earnings and margins
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Revenue growth of ~12% YoY
- Strong cash position offset by high debt‑to‑equity
- Continued volatility and sector cyclicality
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Sustained negative profitability
- Elevated debt load relative to equity
- Uncertain turnaround in a competitive semiconductor testing market
Key Metrics & Analysis
Financial Health
Revenue Growth11.80%
Profit Margin-9.15%
ROE-6.01%
ROA-3.73%
Debt/Equity7.28
P/B Ratio2.3
Op. Cash FlowNT$-3725000
Free Cash FlowNT$-12747125
Industry P/E33.7
Technical Analysis
TrendNeutral
RSI45.7
SupportNT$13.00
ResistanceNT$15.10
MA 20NT$14.19
MA 50NT$14.59
MA 200NT$14.19
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
GradeOvervalued
TypeBlend
Risk Assessment
Beta0.70
Volatility32.94%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.